Paul M. Keane
No más puestos en curso
Perfil
Paul M.
Keane has been Director-Medical Affairs of YM BioSciences, Inc. since 1996.
Dr. Keane was Director of Clinical Research of Miles Canada, Inc. from 1989 to 1995.
He was Professor of Medicine for the University of Calgary.
Antiguos cargos conocidos de Paul M. Keane.
| Empresas | Cargo | Fin |
|---|---|---|
Bayer, Inc.
 Bayer, Inc. Chemicals: AgriculturalProcess Industries Bayer, Inc. manufactures chemicals, healthcare, agricultural, and life science products. The company develops products that fight diseases, protects crops and animals, as well as develops materials. It was founded in 1936 and is headquartered in Toronto, Canada | Director Técnico/Científico/I+D | 01/01/1995 |
| McMaster University | Corporate Officer/Principal | - |
| University of Calgary | Corporate Officer/Principal | - |
YM BioSciences, Inc.
 YM BioSciences, Inc. Pharmaceuticals: MajorHealth Technology YM BioSciences, Inc. operates as a drug development company, which manufactures advancing hematology and cancer-related products. It is currently advancing in late-stage products, which include CYT387, an oral small molecule inhibitor of the kinase enzymes JAK1 and JAK2; and Nimotuzumab, an EGFR targeting humanized monoclonal antibody. The company was founded in 1994 and is headquartered in Mississauga, Canada. | Director Técnico/Científico/I+D | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 2 |
|---|---|
YM BioSciences, Inc.
YM BioSciences, Inc. Pharmaceuticals: MajorHealth Technology YM BioSciences, Inc. operates as a drug development company, which manufactures advancing hematology and cancer-related products. It is currently advancing in late-stage products, which include CYT387, an oral small molecule inhibitor of the kinase enzymes JAK1 and JAK2; and Nimotuzumab, an EGFR targeting humanized monoclonal antibody. The company was founded in 1994 and is headquartered in Mississauga, Canada. | Health Technology |
Bayer, Inc.
Bayer, Inc. Chemicals: AgriculturalProcess Industries Bayer, Inc. manufactures chemicals, healthcare, agricultural, and life science products. The company develops products that fight diseases, protects crops and animals, as well as develops materials. It was founded in 1936 and is headquartered in Toronto, Canada | Process Industries |
- Bolsa de valores
- Insiders
- Paul M. Keane
